{"altmetric_id":2258588,"counts":{"readers":{"mendeley":32,"citeulike":0,"connotea":0},"googleplus":{"unique_users_count":1,"unique_users":["HemaCare Corporation"],"posts_count":1},"total":{"posts_count":11},"twitter":{"unique_users_count":8,"unique_users":["Mohty_EBMT","TheEBMT","Transplant_Doc","SSBMTTawasul","HC_BioResearch","62Shamsi","DrMiguelPerales","bmtojc"],"posts_count":10}},"selected_quotes":["Latest position statement on stem cell mobilization from EBMT","Autologous HSC mobilisation in #myeloma #lymphoma patients: @TheEBMT position statement @Mohty_EBMT #Ebmtitc16","Position statement from the European Group for Blood and Marrow Transplantation on #PBSCs for #myeloma, #lymphoma","Autologous HSC mobilisation in #myeloma #lymphoma patients"],"citation":{"abstract":"Autologous haematopoietic SCT with PBSCs is regularly used to restore BM function in patients with multiple myeloma or lymphoma after myeloablative chemotherapy. Twenty-eight experts from the European Group for Blood and Marrow Transplantation developed a position statement on the best approaches to mobilising PBSCs and on possibilities of optimising graft yields in patients who mobilise poorly. Choosing the appropriate mobilisation regimen, based on patients' disease stage and condition, and optimising the apheresis protocol can improve mobilisation outcomes. Several factors may influence mobilisation outcomes, including older age, a more advanced disease stage, the type of prior chemotherapy (e.g., fludarabine or melphalan), prior irradiation\u00a0or a higher number of prior treatment lines. The most robust predictive factor for poor PBSC collection is the CD34(+) cell count in PB before apheresis. Determination of the CD34(+) cell count in PB before apheresis helps to identify patients at risk of poor PBSC collection and allows pre-emptive intervention to rescue mobilisation in these patients. Such a proactive approach might help to overcome deficiencies in stem cell mobilisation and offers a rationale for the use of novel mobilisation agents.Bone Marrow Transplantation advance online publication, 31 March 2014; doi:10.1038\/bmt.2014.39.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e93cf058f610002414","authors":["Mohty M","H\u00fcbel K","Kr\u00f6ger N","Aljurf M","Apperley J","Basak GW","Bazarbachi A","Douglas K","Gabriel I","Garderet L","Geraldes C","Jaksic O","Kattan MW","Koristek Z","Lanza F","Lemoli RM","Mendeleeva L","Mikala G","Mikhailova N","Nagler A","Schouten HC","Selleslag D","Suciu S","Sureda A","Worel N","Wuchter P","Chabannon C","Duarte RF","M Mohty","K H\u00fcbel","N Kr\u00f6ger","M Aljurf","J Apperley","G W Basak","A Bazarbachi","K Douglas","I Gabriel","L Garderet","C Geraldes","O Jaksic","M W Kattan","Z Koristek","F Lanza","R M Lemoli","L Mendeleeva","G Mikala","N Mikhailova","A Nagler","H C Schouten","D Selleslag","S Suciu","A Sureda","N Worel","P Wuchter","C Chabannon","R F Duarte"],"doi":"10.1038\/bmt.2014.39","endpage":"872","first_seen_on":"2014-04-05T21:36:05+00:00","funders":["dohuk"],"issns":["0268-3369"," 1476-5365","1476-5365"],"issue":"7","journal":"Bone Marrow Transplantation","last_mentioned_on":1473417259,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24686988","http:\/\/www.nature.com\/bmt\/journal\/v49\/n7\/abs\/bmt201439a.html?WT.ec_id=BMT-201407","http:\/\/links.ealert.nature.com\/ctt?b=2&j=NDgwMjc1ODA1S0&kn=71&ms=NDYzNjgyMzMS1&mt=1&r=MTc1NjA3MDk4OQS2&rt=0","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24686988?dopt=Citation"],"pmid":"24686988","pubdate":"2014-04-03T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"865","title":"Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation","type":"article","uri":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2014.39","volume":"49","mendeley_url":"http:\/\/www.mendeley.com\/research\/autologous-haematopoietic-stem-cell-mobilisation-multiple-myeloma-lymphoma-patients-position-stateme-7"},"altmetric_score":{"score":4.6,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":4.6},"context_for_score":{"all":{"total_number_of_other_articles":8352366,"mean":7.0446264010179,"rank":1739870,"this_scored_higher_than_pct":79,"this_scored_higher_than":6604862,"rank_type":"exact","sample_size":8352366,"percentile":79},"similar_age_3m":{"total_number_of_other_articles":179503,"mean":7.5733866920705,"rank":38591,"this_scored_higher_than_pct":78,"this_scored_higher_than":140707,"rank_type":"exact","sample_size":179503,"percentile":78},"this_journal":{"total_number_of_other_articles":1539,"mean":5.0022379713914,"rank":547,"this_scored_higher_than_pct":64,"this_scored_higher_than":990,"rank_type":"exact","sample_size":1539,"percentile":64},"similar_age_this_journal_3m":{"total_number_of_other_articles":30,"mean":1.8451724137931,"rank":4,"this_scored_higher_than_pct":86,"this_scored_higher_than":26,"rank_type":"exact","sample_size":30,"percentile":86}}},"demographics":{"poster_types":{"member_of_the_public":2,"researcher":3,"science_communicator":3},"users":{"twitter":{"cohorts":{"Scientists":3,"Science communicators (journalists, bloggers, editors)":3,"Members of the public":2}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":3,"Student  > Doctoral Student":6,"Researcher":6,"Student  > Ph. D. Student":2,"Student  > Postgraduate":1,"Student  > Master":1,"Other":6,"Student  > Bachelor":5,"Professor":1},"by_discipline":{"Medicine and Dentistry":20,"Chemistry":2,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":6,"Unspecified":3}}},"geo":{"twitter":{"US":2},"mendeley":{"JP":1,"DK":1,"FR":1,"PT":2}}},"posts":{"googleplus":[{"title":"New position statement from the European Group for Blood and Marrow Transplantation on stem cell mobilisation...","url":"https:\/\/plus.google.com\/101142960639929422490\/posts\/VZDwasebLs8","citation_ids":[2258588],"posted_on":"2014-04-06T19:01:26+00:00","summary":"New position statement from the European Group for Blood and Marrow Transplantation on stem cell mobilisation... New position statement from the European Group for Blood and Marrow Transplantation on stem cell mobilisation in multiple myeloma and lymphoma","author":{"name":"HemaCare Corporation","url":"https:\/\/plus.google.com\/+Hemacare","image":"https:\/\/lh6.googleusercontent.com\/-3ARClb8_0cY\/AAAAAAAAAAI\/AAAAAAAAAGw\/u1wylZOGVIo\/photo.jpg?sz=50","id_on_source":"101142960639929422490"}}],"twitter":[{"url":"https:\/\/twitter.com\/Mohty_EBMT\/status\/484437780542791681","license":"datasift","citation_ids":[2258588],"posted_on":"2014-07-02T20:45:41+00:00","author":{"name":"Mohamad Mohty","url":"http:\/\/www.ebmt.org","image":"https:\/\/pbs.twimg.com\/profile_images\/480924346299346944\/OOXDgK3a_normal.jpeg","description":"Professor of Hematology and president of the European society for Blood and Marrrow Transplantation (EBMT)","id_on_source":"Mohty_EBMT","tweeter_id":"2626263112","geo":{"lt":null,"ln":null},"followers":2772},"tweet_id":"484437780542791681"},{"url":"https:\/\/twitter.com\/TheEBMT\/status\/484643162385022976","license":"datasift","rt":["Mohty_EBMT"],"citation_ids":[2258588],"posted_on":"2014-07-03T10:21:48+00:00","author":{"name":"EBMT","url":"http:\/\/www.ebmt.org","image":"https:\/\/pbs.twimg.com\/profile_images\/588605676252860416\/qJJY6Y5k_normal.jpg","description":"The European Society for Blood and Marrow Transplantation's mission is to save the lives of patients with blood cancers and other life-threatening diseases.","id_on_source":"TheEBMT","tweeter_id":"1617240518","geo":{"lt":null,"ln":null},"followers":2347},"tweet_id":"484643162385022976"},{"url":"https:\/\/twitter.com\/Transplant_Doc\/status\/485452434701955073","license":"datasift","rt":["Mohty_EBMT"],"citation_ids":[2258588],"posted_on":"2014-07-05T15:57:34+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"Transplant_Doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3419},"tweet_id":"485452434701955073"},{"url":"https:\/\/twitter.com\/SSBMTTawasul\/status\/485473950579716097","license":"datasift","rt":["Mohty_EBMT"],"citation_ids":[2258588],"posted_on":"2014-07-05T17:23:04+00:00","author":{"name":"TawasulLinks \u062a\u0648\u0627\u0635\u0644","url":"http:\/\/www.ssbmt.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2321925266\/rc4ek8pgskpdvqx0n9ei_normal.jpeg","description":"Tawasul\/Links a newsletter of the Saudi Society of Blood and Marrow Transplantation. www.ssbmt.org \u062a\u0648\u0627\u0635\u0644.\u0627\u0644\u0645\u062c\u0644\u0647 \u0627\u0644\u0631\u0633\u0645\u064a\u0647 \u0644\u0644\u062c\u0645\u0639\u064a\u0647 \u0627\u0644\u0633\u0639\u0648\u062f\u064a\u0647 \u0644\u0632\u0631\u0627\u0639\u0629 \u0627\u0644\u062e\u0644\u0627\u064a\u0627 \u0627\u0644\u062c\u0630\u0639\u064a\u0647","id_on_source":"SSBMTTawasul","tweeter_id":"592173968","geo":{"lt":null,"ln":null},"followers":547},"tweet_id":"485473950579716097"},{"url":"http:\/\/twitter.com\/HC_BioResearch\/status\/452560182623879168","license":"public","citation_ids":[2258588],"posted_on":"2014-04-05T21:35:30+00:00","author":{"name":"HemaCare BioResearch","url":"http:\/\/www.hemacare.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3118235023\/9e1c4c219d6b67e7edbcb017fd16c24d_normal.png","description":"Leading supplier of apheresis products & customized #primary #cells from peripheral blood, bone marrow, & cord blood for #research and #celltherapy","id_on_source":"HC_BioResearch","tweeter_id":"1096512024","geo":{"lt":34.18667,"ln":-118.44897,"country":"US"},"followers":752},"tweet_id":"452560182623879168"},{"url":"https:\/\/twitter.com\/62Shamsi\/status\/485666134512107520","license":"datasift","rt":["Mohty_EBMT"],"citation_ids":[2258588],"posted_on":"2014-07-06T06:06:44+00:00","author":{"name":"Tahir Shamsi","url":"http:\/\/www.nibd.edu.pk","image":"https:\/\/pbs.twimg.com\/profile_images\/439955171507191808\/lJuf5OOR_normal.jpeg","description":"Dr. Tahir S. Shamsi, Professor of Clinical Haematology, Consultant Haematologist & Transplant Physician. Affiliated with NIBD & BMT, Karachi, Pakistan","id_on_source":"62Shamsi","tweeter_id":"2342993066","geo":{"lt":null,"ln":null},"followers":407},"tweet_id":"485666134512107520"},{"url":"http:\/\/twitter.com\/DrMiguelPerales\/statuses\/774182405837950976","license":"gnip","citation_ids":[2258588],"posted_on":"2016-09-09T09:47:23+00:00","author":{"name":"Miguel Perales M.D.","url":"http:\/\/www.mskcc.org\/cancer-care\/doctor\/miguel-angel-perales","image":"https:\/\/pbs.twimg.com\/profile_images\/420287281832787968\/QqvGIWhX_normal.jpeg","description":"Oncologist @sloan_kettering. Stem cell transplantation Lymphoma Leukemia MDS Myeloma Immunotherapy Vaccines. @BeTheMatch & @ASBMT Board Member. Tweets mine.","id_on_source":"DrMiguelPerales","tweeter_id":"1407780158","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":6676},"tweet_id":"774182405837950976"},{"url":"http:\/\/twitter.com\/Mohty_EBMT\/statuses\/774183449837961216","license":"gnip","rt":["DrMiguelPerales"],"citation_ids":[2258588],"posted_on":"2016-09-09T09:51:32+00:00","author":{"name":"Mohamad Mohty","url":"http:\/\/www.ebmt.org","image":"https:\/\/pbs.twimg.com\/profile_images\/480924346299346944\/OOXDgK3a_normal.jpeg","description":"Professor of Hematology and president of the European society for Blood and Marrrow Transplantation (EBMT)","id_on_source":"Mohty_EBMT","tweeter_id":"2626263112","geo":{"lt":null,"ln":null},"followers":2772},"tweet_id":"774183449837961216"},{"url":"http:\/\/twitter.com\/TheEBMT\/statuses\/774190852151373824","license":"gnip","rt":["DrMiguelPerales"],"citation_ids":[2258588],"posted_on":"2016-09-09T10:20:57+00:00","author":{"name":"EBMT","url":"http:\/\/www.ebmt.org","image":"https:\/\/pbs.twimg.com\/profile_images\/588605676252860416\/qJJY6Y5k_normal.jpg","description":"The European Society for Blood and Marrow Transplantation's mission is to save the lives of patients with blood cancers and other life-threatening diseases.","id_on_source":"TheEBMT","tweeter_id":"1617240518","geo":{"lt":null,"ln":null},"followers":2347},"tweet_id":"774190852151373824"},{"url":"http:\/\/twitter.com\/bmtojc\/statuses\/774194216775757824","license":"gnip","rt":["DrMiguelPerales"],"citation_ids":[2258588],"posted_on":"2016-09-09T10:34:19+00:00","author":{"name":"BMT Journal Club","url":"http:\/\/www.bmtojc.net","image":"https:\/\/pbs.twimg.com\/profile_images\/534073284682194944\/KlT5ElF5_normal.jpeg","description":"@ASBMT Online Journal Club - Stem cell transplantation. Leukemia. Lymphoma. MDS. Myeloma. #bmtsm","id_on_source":"bmtojc","tweeter_id":"2901976374","geo":{"lt":null,"ln":null},"followers":681},"tweet_id":"774194216775757824"}]}}